Survey Outlines Lung Cancer Survivors’ Views on Telerehabilitation
“Telerehabilitation interventions for lung cancer survivors following curative intent therapy may need to include strategies to improve self-efficacy and telemedicine skills, according to new survey results published in BMJ Open.”
Black People With Lung Cancer Can Find Community in Support Groups
“How one cancer survivor found many shoulders to lean on during her journey.”
Fitzpatrick’s bipartisan bill would increase lung cancer screening rates nationwide
“Bipartisan legislation introduced on June 22 by U.S. Rep. Brian Fitzpatrick (R-PA) aims to increase the number of Americans who are screened for lung cancer and reduce barriers to preventative care in the nation’s underserved areas.”
eNose Breath Analysis Detects Early-Stage Lung Cancer in Patients With COPD
“Early-stage asymptomatic lung cancer in patients with chronic obstructive pulmonary disease (COPD) may be identified using molecular profiling of exhaled breath using an electronic technology called “eNose,” according study findings published in Chest.”
How a novel drug may improve survival rate for people with some types of lung cancer
“Adjuvant chemotherapy is less effective in people with non-small cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor (EGFR) gene than those with the wild-type version of the gene.”
How Long Do Lung Cancer Patients Need to Stay on Immunotherapy?
“Responders may be able to discontinue immune checkpoint inhibitors after two years with no decrease in survival.”
Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases.
“Lung cancer prevails and induces high mortality around the world. This study provided real-world information on the evolution of clinicopathological profiles and survival outcomes of lung cancer, and provided survival information within finer stage I subtypes.”
A Gaping Hole in Cancer-Therapy Trials
“Treatments aren’t widely tested on older patients—the very people who need them most.”
Therapy Selection in Small Cell Lung Cancer With Disease Progression After Platinum-Based Therapy
“Platinum-based therapies, commonly used for SCLC, unfortunately prove ineffective for certain patients. As a result, ongoing clinical trials are diligently investigating alternative treatments to identify potential options for this specific patient population.”
Pembrolizumab Maintains Efficacy After 5 Years in First-Line, PD-L1+, Advanced NSCLC
“Findings from the 5-year follow-up analysis of the phase 3 KEYNOTE-042 study continue to support frontline pembrolizumab as standard of care for PD-L1-positive, locally advanced/metastatic non–small cell lung cancer.”
Treatment for EGFR-Mutant NSCLC Varies by Driver
“In an interview with Targeted Oncology, Nicholas Girard, MD, PhD reviews 3 key abstracts presented at the ELCC 2023, in which different targeted therapies were administered to patients with EGFR-mutant non–small cell lung cancer in clinical trial and real-world settings.”
Radon exposure and lung cancer: 11 things to know
“After smoking, radon exposure is considered the second most common cause of lung cancer in the United States. It is usually suspected when someone who has never smoked or lived around anyone who smokes is diagnosed with lung cancer.”
